Precise Robotically IMplanted Brain-Computer InterfacE

Last updated: January 7, 2026
Sponsor: Neuralink Corp
Overall Status: Active - Recruiting

Phase

N/A

Condition

Limb Spasticity

Myasthenia Gravis (Chronic Weakness)

Amyotrophic Lateral Sclerosis (Als)

Treatment

N1 Implant

R1 Robot

Clinical Study ID

NCT06429735
N1-EFS-001
  • Ages 22-75
  • All Genders

Study Summary

The PRIME Study is a first-in-human early feasibility study to evaluate the initial clinical safety and device functionality of the Neuralink N1 Implant and R1 Robot device designs in participants with tetraparesis or tetraplegia. The N1 Implant is a skull-mounted, wireless, rechargeable implant connected to electrode threads that are implanted in the brain by the R1 Robot, a robotic electrode thread inserter.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Severe quadriplegia (tetraplegia) due to spinal cord injury or amyotrophic lateral sclerosis (ALS) for at least 1 year without improvement, where quadriplegia is defined as having very limited or no hand, wrist, and arm movement and all levels below

  • Life expectancy ≥ 12 months.

  • Ability to communicate in English

  • Presence of a stable caregiver

Exclusion Criteria

  • Moderate to high risk for serious perioperative adverse events

  • Active implanted devices

  • Morbid obesity (Body Mass Index > 40)

  • History of poorly controlled seizures or epilepsy

  • History of poorly controlled diabetes

  • Requires magnetic resonance imaging (MRI) for any ongoing medical conditions

  • Acquired or hereditary immunosuppression

  • Use of smoking tobacco or other tobacco products

  • Psychiatric or psychological disorder

  • Brain MRI demonstrating hemorrhage, tumor, distorted or adverse anatomy.

  • Any condition which, in the opinion of the Investigator, would compromise your ability to safely participate in the study or undergo the implantation procedure

Study Design

Total Participants: 15
Treatment Group(s): 2
Primary Treatment: N1 Implant
Phase:
Study Start date:
January 09, 2024
Estimated Completion Date:
January 31, 2031

Connect with a study center

  • Barrow Neurological Institute

    Phoenix, Arizona 85013
    United States

    Site Not Available

  • Barrow Neurological Institute

    Phoenix 5308655, Arizona 5551752 85013
    United States

    Active - Recruiting

  • University of Miami

    Miami, Florida 33136
    United States

    Site Not Available

  • University of Miami

    Miami 4164138, Florida 4155751 33136
    United States

    Active - Recruiting

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.